CXCL8 and melanoma: We have previously shown that angiogenesis can be inhibited with antibodies against VEGF-A, IL-8, bFGF or PD-ECGF in the melanoma models included in the current study, and that the melanoma models differ in the secretion rate of these angiogenic stimulators [29].